Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Confirmation of the Cardioprotective Effect of MitoGamide in the Diabetic Heart.
Park M, Nishimura T, Baeza-Garza CD, Caldwell ST, Pun PBL, Prag HA, Young T, Sauchanka O, Logan A, Forkink M, Gruszczyk AV, Prime TA, Arndt S, Naudi A, Pamplona R, Coughlan MT, Tate M, Ritchie RH, Caicci F, Kaludercic N, Di Lisa F, Smith RAJ, Hartley RC, Murphy MP, Krieg T. Park M, et al. Among authors: coughlan mt. Cardiovasc Drugs Ther. 2020 Dec;34(6):823-834. doi: 10.1007/s10557-020-07086-7. Epub 2020 Sep 26. Cardiovasc Drugs Ther. 2020. PMID: 32979176 Free PMC article.
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart.
Tate M, Higgins GC, De Blasio MJ, Lindblom R, Prakoso D, Deo M, Kiriazis H, Park M, Baeza-Garza CD, Caldwell ST, Hartley RC, Krieg T, Murphy MP, Coughlan MT, Ritchie RH. Tate M, et al. Among authors: coughlan mt. Cardiovasc Drugs Ther. 2019 Dec;33(6):669-674. doi: 10.1007/s10557-019-06914-9. Cardiovasc Drugs Ther. 2019. PMID: 31654171 Free PMC article.
Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart.
Tate M, Higgins GC, De Blasio MJ, Lindblom R, Prakoso D, Deo M, Kiriazis H, Park M, Baeza-Garza CD, Caldwell ST, Hartley RC, Krieg T, Murphy MP, Coughlan MT, Ritchie RH. Tate M, et al. Among authors: coughlan mt. Cardiovasc Drugs Ther. 2020 Apr;34(2):223. doi: 10.1007/s10557-019-06929-2. Cardiovasc Drugs Ther. 2020. PMID: 32062792 Free PMC article.
Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy.
Parker AM, Tate M, Prakoso D, Deo M, Willis AM, Nash DM, Donner DG, Crawford S, Kiriazis H, Granata C, Coughlan MT, De Blasio MJ, Ritchie RH. Parker AM, et al. Among authors: coughlan mt. Front Physiol. 2021 Sep 1;12:672252. doi: 10.3389/fphys.2021.672252. eCollection 2021. Front Physiol. 2021. PMID: 34539423 Free PMC article.
Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy.
Tan AL, Sourris KC, Harcourt BE, Thallas-Bonke V, Penfold S, Andrikopoulos S, Thomas MC, O'Brien RC, Bierhaus A, Cooper ME, Forbes JM, Coughlan MT. Tan AL, et al. Among authors: coughlan mt. Am J Physiol Renal Physiol. 2010 Mar;298(3):F763-70. doi: 10.1152/ajprenal.00591.2009. Epub 2009 Dec 16. Am J Physiol Renal Physiol. 2010. PMID: 20015941 Free article.
Targeted reduction of advanced glycation improves renal function in obesity.
Harcourt BE, Sourris KC, Coughlan MT, Walker KZ, Dougherty SL, Andrikopoulos S, Morley AL, Thallas-Bonke V, Chand V, Penfold SA, de Courten MP, Thomas MC, Kingwell BA, Bierhaus A, Cooper ME, de Courten B, Forbes JM. Harcourt BE, et al. Among authors: coughlan mt. Kidney Int. 2011 Jul;80(2):190-8. doi: 10.1038/ki.2011.57. Epub 2011 Mar 16. Kidney Int. 2011. PMID: 21412218 Free article. Clinical Trial.
97 results